ES2034642T3 - Un procedimiento para preparar derivados de 1,5-benzotiazepina y su utilizacion en el tratamiento de las alteraciones cardiovasculares. - Google Patents

Un procedimiento para preparar derivados de 1,5-benzotiazepina y su utilizacion en el tratamiento de las alteraciones cardiovasculares.

Info

Publication number
ES2034642T3
ES2034642T3 ES198989307564T ES89307564T ES2034642T3 ES 2034642 T3 ES2034642 T3 ES 2034642T3 ES 198989307564 T ES198989307564 T ES 198989307564T ES 89307564 T ES89307564 T ES 89307564T ES 2034642 T3 ES2034642 T3 ES 2034642T3
Authority
ES
Spain
Prior art keywords
hydrogen
treatment
alkyl
benzotiazepine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989307564T
Other languages
English (en)
Inventor
Hiroaki Cno Sankyo Company Limited Yanagisawa
Koichi Cno Sankyo Company Limited Fujimoto
Yasuo Cno Sankyo Company Limited Shimoji
Takuro Cno Sankyo Company Limited Kanazaki
Hiroyuki Cno Sankyo Company Limited Koike
Hiroshi Cno Sankyo Company Limited Nishino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2034642T3 publication Critical patent/ES2034642T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

COMPUESTOS DE FORMULA (I), DONDE R1 ES ARILO O HETEROCICLILO AROMATICO; R2 Y R3 SON HIDROGENO, ALQUILO, ALCOXI, HALOGENO, FENOXI, ALQUILTIO C1-C6, FENILTIO, HALOALQUILO C1-C6, CIANO O NITRO, O JUNTOS SON ALQUILENO QUE, OPCIONALMENTE, CONTIENE OXIGENO; R4 ES HIDROGENO, ACILO ALIFATICO, CICLOALQUILCARBONILO, CICLOALCOXICARBONILO, ACILO AROMATICO, ALCOXICARBONILO O BENCILOXICARBONILO; R5 Y R6 SON ALQUILO; Y X ES OXIGENO, AZUFRE O METILENO, TIENEN ACTIVIDAD BLOQUEANTE DEL CANAL DE CALCIO Y PUEDEN SERVIR PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES Y DESORDENES CARDIOVASCULARES. SE PUEDEN OBTENER POR REACCION DE UN COMPUESTO CORRESPONDIENTE, DONDE R4 ES HIDROGENO Y EL GRUPO AMINOETILO ESTA SUSTITUIDO POR HIDROGENO, CON UN COMPUESTO QUE PROPORCIONA EL GRUPO AMINOETILO Y LUEGO, SI SE DESEA, ACILAR EL PRODUCTO.
ES198989307564T 1988-07-25 1989-07-25 Un procedimiento para preparar derivados de 1,5-benzotiazepina y su utilizacion en el tratamiento de las alteraciones cardiovasculares. Expired - Lifetime ES2034642T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18509788 1988-07-25
JP26754088 1988-10-24
JP4102489 1989-02-21

Publications (1)

Publication Number Publication Date
ES2034642T3 true ES2034642T3 (es) 1993-04-01

Family

ID=27290681

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989307564T Expired - Lifetime ES2034642T3 (es) 1988-07-25 1989-07-25 Un procedimiento para preparar derivados de 1,5-benzotiazepina y su utilizacion en el tratamiento de las alteraciones cardiovasculares.

Country Status (8)

Country Link
US (1) US5002942A (es)
EP (1) EP0353032B1 (es)
KR (1) KR940003291B1 (es)
CA (1) CA1336712C (es)
DE (1) DE68900867D1 (es)
ES (1) ES2034642T3 (es)
GR (1) GR3004725T3 (es)
IE (1) IE62994B1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255545B (it) * 1992-10-23 1995-11-09 Procedimento per la preparazione di diltiazem
DK0702009T3 (da) * 1994-09-16 1999-02-01 Orion Corp Fermion Fremgangsmåde til fremstilling af farmaceutisk aktive benzothiazepinderivater
FI97725C (fi) * 1995-02-17 1997-02-10 Orion Yhtymae Oy Menetelmä diltiatseemin valmistamiseksi
US5709897A (en) * 1995-09-12 1998-01-20 Pearlstein; Leonard Absorbent packaging for food products
JP4875561B2 (ja) * 2007-07-20 2012-02-15 株式会社クボタ 作業車のサスペンション構造
US8501727B2 (en) * 2008-08-22 2013-08-06 Milestone Pharmaceuticals Inc. Short acting benzothiazepine calcium channel blockers and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55167282A (en) * 1979-06-12 1980-12-26 Fujisawa Pharmaceut Co Ltd Piperazine derivative or its salt and its preparation
DE3064910D1 (en) * 1979-06-12 1983-10-27 Fujisawa Pharmaceutical Co 2-oxo-benzothiazoline, benzoxazoline or indoline derivatives, their preparation, and pharmaceutical compositions comprising such derivatives
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
US4594342A (en) * 1984-04-10 1986-06-10 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivative

Also Published As

Publication number Publication date
IE892409L (en) 1990-01-25
IE62994B1 (en) 1995-03-08
CA1336712C (en) 1995-08-15
KR940003291B1 (ko) 1994-04-20
EP0353032A1 (en) 1990-01-31
US5002942A (en) 1991-03-26
KR910002821A (ko) 1991-02-26
DE68900867D1 (de) 1992-04-02
GR3004725T3 (es) 1993-04-28
EP0353032B1 (en) 1992-02-26

Similar Documents

Publication Publication Date Title
HUT60250A (en) Process for producing new phenylimidazolidines, their thione and iminoderivatives, and pharmaceutical compositions comprising same as active ingredient
WO1998050346A3 (en) Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders
DK0705244T3 (da) Nitrato-aminosyredisulfid til behandling af sygdomme i det cardiovaskulære system
DE69121317T2 (de) Pharmazeutisch wirksame ZNS-Verbindung
ATE414524T1 (de) Verwendung von myoblasten zur herstellung eines medikaments zur behandlung der stressbedingten harninkontinenz
ATE251624T1 (de) Granulatimide-derivate zur behandlung von krebs
ATE58126T1 (de) Aminderivate, verfahren zu ihrer herstellung und diese enthaltende fungizide.
ES2034642T3 (es) Un procedimiento para preparar derivados de 1,5-benzotiazepina y su utilizacion en el tratamiento de las alteraciones cardiovasculares.
ES484784A1 (es) Procedimiento para la obtencion de n-benzoil-n'-terc.-alco- xicarbonilfenil-(tio)ureas sustituidas, de efecto insectici-da
ATE107275T1 (de) N-phenyl-n'-alkylsulfonylharnstoffe, verfahren zu ihrer herstellung und diese enthaltende antitumorzusammensetzungen.
DE3787844T2 (de) Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen.
DE69523581T2 (de) Anti-helicobacter ester- oder carbamatderivate von azolonen
ES8500896A1 (es) Procedimiento para la obtencion de 1-fenil-3-benzoil-(tio)-ureas
ATE140693T1 (de) Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.
DE68903907T2 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
ATE16926T1 (de) N-benzoyl-n'-phenoxyphenylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen.
ATE88460T1 (de) Verbindungen zur behandlung von harninkontinenz.
ATE100102T1 (de) Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
MX25922A (es) Pirido (3,4-b) pirrolo (1,2-e)(1,4,5)oxadiazepinasy compuestos analogos relacionados un procedimiento para su preparacion y su uso como medicamentos
DE69027577D1 (de) Verwendung von Benzothiazepinen zur Herstellung von Arzneimitteln zur Behandlung von epileptischen Anfällen
ES2102774T3 (es) Indolsulfonamidas como agentes antitumorales.
AR246506A1 (es) Esteres de acido fenilacetico sustituido, procedimiento para prepararlos y composiciones plaguicidas de accion insecticida y acaricida que los contienen.
ATE92077T1 (de) Enzymhemmer und methode zu dessen herstellung.
MY103239A (en) A benzoylurea derivative and its production and use

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 353032

Country of ref document: ES